Search details
1.
On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates.
Breast Cancer Res
; 25(1): 4, 2023 01 12.
Article
in English
| MEDLINE | ID: mdl-36635767
2.
First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors.
Invest New Drugs
; 40(5): 1001-1010, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35802288
3.
Blood Test for Breast Cancer Screening through the Detection of Tumor-Associated Circulating Transcripts.
Int J Mol Sci
; 23(16)2022 Aug 15.
Article
in English
| MEDLINE | ID: mdl-36012405
4.
Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor-positive, HER2-negative metastatic breast cancer.
Int J Cancer
; 2021 Apr 27.
Article
in English
| MEDLINE | ID: mdl-33905134
5.
Risk of Lymphedema Following Contemporary Treatment for Breast Cancer: An Analysis of 7617 Consecutive Patients From a Multidisciplinary Perspective.
Ann Surg
; 274(1): 170-178, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-31348041
6.
Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations.
Invest New Drugs
; 39(5): 1366-1374, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33723724
7.
Use of bevacizumab before or after radiotherapy increases the risk of fistula formation in patients with cervical cancer.
Int J Gynecol Cancer
; 31(1): 59-65, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33273018
8.
Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer.
Breast Cancer Res Treat
; 183(2): 493, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32661666
9.
Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer.
Breast Cancer Res Treat
; 183(1): 107-116, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32577940
10.
Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older.
Breast Cancer Res Treat
; 179(3): 687-697, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31811505
11.
Cardiotoxicity evaluation using magnetic resonance imaging in breast Cancer patients (CareBest): study protocol for a prospective trial.
BMC Cardiovasc Disord
; 20(1): 264, 2020 06 03.
Article
in English
| MEDLINE | ID: mdl-32493217
12.
Changes in taste and food preferences in breast cancer patients receiving chemotherapy: a pilot study.
Support Care Cancer
; 28(3): 1265-1275, 2020 Mar.
Article
in English
| MEDLINE | ID: mdl-31230121
13.
Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 20(12): 1750-1759, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31668850
14.
Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review.
Int J Cancer
; 145(5): 1179-1188, 2019 09 01.
Article
in English
| MEDLINE | ID: mdl-30478914
15.
Effect of primary tumor resection on overall survival in patients with stage IV breast cancer.
Breast J
; 25(5): 908-915, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31187565
16.
A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial.
Int J Cancer
; 143(12): 3240-3247, 2018 12 15.
Article
in English
| MEDLINE | ID: mdl-29978467
17.
Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer.
Breast Cancer Res Treat
; 163(2): 255-262, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-28243895
18.
Chemotherapy-induced irreversible alopecia in early breast cancer patients.
Breast Cancer Res Treat
; 163(3): 527-533, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-28324267
19.
A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors.
Invest New Drugs
; 35(6): 773-781, 2017 12.
Article
in English
| MEDLINE | ID: mdl-28353123
20.
Prevalence and prognostic implications of psychological distress in patients with gastric cancer.
BMC Cancer
; 17(1): 283, 2017 04 20.
Article
in English
| MEDLINE | ID: mdl-28427439